Tapering Lamotrigine from 400 mg to 200 mg
Reduce lamotrigine by approximately 50% per week over a minimum 2-week period, which translates to decreasing from 400 mg to 300 mg for week 1, then to 200 mg for week 2 and beyond. 1
Tapering Schedule
The FDA label explicitly states that unless safety concerns require more rapid withdrawal, lamotrigine should be tapered over a period of at least 2 weeks with approximately 50% reduction per week 1. This is critical to minimize the risk of withdrawal seizures in patients with epilepsy.
Recommended Taper:
- Week 1: 300 mg daily (25% reduction)
- Week 2: 200 mg daily (target dose achieved)
Alternatively, for a more conservative approach:
- Week 1: 350 mg daily
- Week 2: 300 mg daily
- Week 3: 250 mg daily
- Week 4: 200 mg daily
Critical Considerations
Withdrawal seizures are a real risk. The FDA specifically warns against abrupt discontinuation, noting that in patients with epilepsy there is a possibility of increasing seizure frequency 1. Even when reducing dose rather than stopping completely, this principle applies.
Concomitant medications matter significantly:
- If the patient is taking valproate, they are already on a regimen where lamotrigine clearance is reduced by approximately 50%. The taper can proceed as outlined above, but monitor closely for toxicity signs (dizziness, ataxia, diplopia) 1.
- If taking enzyme-inducing AEDs (carbamazepine, phenytoin, phenobarbital, primidone), lamotrigine clearance is enhanced, and the standard taper applies 1.
- If taking oral contraceptives, be aware that lamotrigine levels may fluctuate, potentially doubling during the pill-free week 1.
Monitoring During Taper
Watch for:
- Seizure frequency increase (if treating epilepsy)
- Mood destabilization (if treating bipolar disorder) - particularly emergence of depressive symptoms, as lamotrigine is most effective for preventing depression 2
- Adverse effects from elevated levels during the taper: dizziness, ataxia, diplopia, headache 3
Common Pitfalls to Avoid
Do not taper faster than 2 weeks unless there is a serious safety concern (e.g., severe rash, Stevens-Johnson syndrome). Rapid discontinuation increases seizure risk substantially 1.
Do not assume all patients tolerate the same taper rate. While the 2-week minimum is standard, some patients may require slower tapers, particularly those with poorly controlled seizures or significant mood instability.
Do not forget to adjust for drug interactions. The presence or absence of valproate or enzyme-inducing medications fundamentally changes lamotrigine pharmacokinetics and may require modification of the tapering schedule 1.